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Abstract
We have investigated the functional coupling of K and L isoforms of the human thromboxane A2 receptor (TP) to GK16
and GK12 members of the Gq and G12 families of heterotrimeric G proteins in human embryonic kidney (HEK) 293 cell lines
HEK.K10 or HEK.L3, stably over-expressing TPK and TPL, respectively. Moreover, using HEK.TPv328 cells which over-
express a variant of TP truncated at the point of divergence of TPK and TPL, we investigated the requirement of the C-tail
per se in mediating G protein coupling and effector activation. Both TPK and TPL couple similarly to GK16 to affect increases
in inositol 1,4,5-trisphosphate (IP3) and mobilisation of intracellular calcium ([Ca2]i) in response to the TP agonist U46619.
Whilst both TP isoforms mediated [Ca2]i mobilisation in cells co-transfected with GK12, neither receptor generated
corresponding increases in IP3, indicating that the GK12-mediated increases in [Ca2]i do not involve PLC activation.
Verapamil, an inhibitor of voltage dependent Ca2 channels, reduced [Ca2]i mobilisation in TPK and TPL cells co-
transfected with GK12 to approximately 40% of that mobilised in its absence, whereas [8-(N,N-diethylamino)-octyl-3,4,5-
trimethoxybenzoate, hydrochloride] (TMB-8), an antagonist of intracellular Ca2 release, had no effect on [Ca2]i
mobilisation by either receptor isoform co-transfected with GK12. Despite the lack of differential coupling specificity by TPK
and TPL, TPv328 signalled more efficiently in the absence of a co-transfected G protein compared to the wild type receptors
but, on the other hand, displayed an impaired ability to couple to co-transfected GK11, GK12 or GK16 subunits. In studies
investigating the role of the C-tail in influencing coupling to the effector adenylyl cyclase, similar to TPK but not TPL, TPv328
coupled to GKs, leading to increased adenosine 3P,5P-cyclic monophosphate (cAMP), rather than to GKi. Whereas TPv328
signalled more efficiently in the absence of co-transfected G protein compared to the wild type TPK, co-transfection of GKs
did not augment cAMP generation by TPv328. Hence, from these studies involving the wild type TPK, TPL and TPv328, we
conclude that the C-tail sequences of TP are not a major determinant of G protein coupling specificity to GK11 and GK16
members of the Gq family or to GK12 ; it may play a role in determining Gs versus Gi coupling and may act as a determinant
of coupling efficiency. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Heterotrimeric G proteins couple signals from sev-
en transmembrane domain, G protein-coupled recep-
tors (GPCRs) to a host of intracellular e¡ectors [1].
Agonist-activated GPCRs interact with the GDP-
bound heterotrimer leading to GDP^GTP exchange
and dissociation of the GK subunit from the GLQ
subunit. In addition to their regulatory e¡ects on
the GK subunits, the GLQ dimers may also transmit
various intracellular signals [1^3]. However, despite
the many activities of the GLQ dimers, it is believed
that it is the GK subunit of the heterotrimeric G
protein which principally dictates its interaction
with a speci¢c receptor. On the basis of the amino
acid identities of their K subunits, heterotrimeric G
proteins are divided into four subfamilies: Gs, Gi, Gq
and G12 [4]. G protein:e¡ector coupling has been
studied in most detail for Gs, Gi, Gq families whereas
the main e¡ector targets of the G12 family are un-
clear. The G12 subfamily consists of the ubiquitously
expressed members GK12 and GK13. They share a
67% sequence identity and exhibit least homology
(45%) to other G protein K subunits [5]. Whereas
GKq and GK11 are widely expressed and are primar-
ily responsible for pertussis toxin-insensitive phos-
pholipase CL (PLCL) activation, the expression of
GK14 and GK15/GK16 is restricted to a few tissues
[6,7]. For example, GK16 is particularly abundant in
and primarily expressed in hematopoietic cells [7,8].
In the case of the GPCR for thromboxane (TX)
A2, termed TP, the major mode of signaling is acti-
vation of L isozymes of PLC leading to phosphati-
dylinositol turnover and release of calcium from in-
tracellular stores ([Ca2]i) [9]. There are two TP
isoforms in humans, TPK and TPL, which are iden-
tical for their ¢rst 328 amino acids and di¡er exclu-
sively in their carboxyl-terminal cytoplasmic tails
(C-tails) due to alternative splicing within exon 3 of
the TP gene [10,11]. The prostaglandin (PG) E2 re-
ceptor subtype EP3 from a number of species also
has several splice variants which di¡er only in their
C-tails [12^16]. In the case of the bovine EP3 recep-
tors, di¡erences in the C-tails have been shown to
a¡ect G protein coupling speci¢city and intracellular
signaling [12]. Using a variety of approaches involv-
ing either reconstitution studies [17,18], co-puri¢ca-
tion or co-immunoprecipitation experiments [19^21],
photo-cross linking studies with GTP analogs [22] or
co-expression studies [23^26], various investigators
have proposed that the platelet TPs might couple
to the heterotrimeric G proteins Gq, G12, G13, G16
and Gi2. In studies involving the cloned receptor, co-
expression of the TPK isoform with either Gq or G13
increased its a⁄nity for I-BOP in COS-7 cells [23] ;
whereas co-expression of G12 alone had no e¡ect on
a⁄nity, being only able to augment the G13 e¡ect. It
has also been demonstrated that TPK can function-
ally couple to both Gq and G11 following stimulation
with the selective TXA2 mimetic, U46619 and the
isoprostane, 8-epi PGF2K, to mobilise [Ca2]i [26].
Coupling to G11 was more e⁄cient than that to
Gq. Whereas both TP isoforms couple similarly to
G11 in stably transfected HEK 293 cells [27], they
oppositely regulate adenylyl cyclase activity in trans-
fected Chinese hamster ovary (CHO) cells [28], sug-
gesting a possible role for the C-tail of TP in deter-
mining G protein speci¢city. Moreover, Gh, the
novel high molecular weight G protein which may
also function as a transglutaminase [29^32], can me-
diate agonist activation of TPK, but not TPL, leading
to inositol phosphate production due to PLC activa-
tion [33].
Whereas many of these studies have implicated
various G protein K subunits in mediating TP acti-
vation and the latter studies [28,33] indicate that the
TP isoforms may indeed di¡erentially couple to Gs,
Gi and Gh, few studies have directly compared the
e¡ect of members of the Gq or G12 family on signal-
ing by the individual TPK or TPL isoforms. Thus, in
this study, we have investigated the e¡ect of co-ex-
pression of the hematopoietic GK16 and the ubiqui-
tous GK12 on agonist-mediated second messenger
generation in HEK 293 cells stably over-expressing
TPK (HEK.K10 cells) or TPL (HEK.L3 cells) and
compared it to TP signaling in the presence of
GK11. Moreover, in similar studies using
HEK.TPv328 cells, which over-express a variant of
TP (TPv328) truncated at amino acid 328 at the point
of divergence of TPK and TPL, we investigated the
requirement of a C-tail per se in mediating G protein
coupling and e¡ector activation. Our results indi-
cated that both TPK and TPL couple similarly to
GK16 to a¡ect increases in inositol 1,4,5-trisphos-
phate (IP3) and mobilisation of [Ca2]i in response
to the TXA2 mimetic U46619. Whilst both TPK and
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TPL mediated [Ca2]i mobilisation in cells co-trans-
fected with GK12, there was no corresponding eleva-
tion of IP3 for either cell type indicating that G12-
mediated increases in intracellular Ca2 levels are by
a mechanism which does not involve PLCL activa-
tion. Verapamil, an inhibitor of voltage dependent
Ca2 channels, principally the L-type channels [34],
reduced [Ca2]i mobilisation in HEK.K10 or
HEK.L3 cells co-transfected with GK12 whereas
TMB-8, which selectively blocks release of Ca2
from intracellular stores [35], had no signi¢cant e¡ect
on [Ca2]i mobilisation by either receptor isoform
when co-transfected with GK12. Despite the apparent
lack of G protein coupling selectivity conferred by
the di¡erent C-tails of TPK and TPL, TPv328 ap-
peared to signal in the absence of co-transfected G
protein and displayed an impaired ability to couple
to co-transfected GK11, GK16 or GK12 subunits. Tak-
en together, these data indicate that although the
C-tail of TP is apparently not a major determinant
of G protein coupling speci¢city to Gq (GK11 or
GK16) or GK12 members, it is required for e⁄cient
G protein interaction. To extend these studies, as
TPK and TPL di¡er exclusively in their C-tail sequen-
ces and they oppositely regulate adenylyl cyclase, we
investigated TPv328 signaling to the e¡ector adenylyl
cyclase. Similar to the TPK, but not the TPL, iso-
form, TPv328 exhibited U46619-mediated activation
of adenylyl cyclase, with concomitant increases in
adenosine 3P,5P-cyclic monophosphate (cAMP) gen-
eration. However, TPv328 exhibited signi¢cantly
(P = 0.002) higher cAMP generation than TPK in
the absence of exogenous G protein, yet displayed
an impaired ability to couple to co-transfected GKs.
2. Materials and methods
2.1. Materials
The following chemicals were obtained from Cay-
man Chemical Company: 5-heptenoic acid, 7-[6-(3-
hydroxy-1-octenyl)-2-oxabicyclo [2.2.1] hept-5-yl]-
[1R-[1K,4K,5L(z),6K(1E,3S*)]]-9,11-dideoxy-9K,11K-
methanoepoxy PGF2K (U46619); 5-heptenoic acid, 7-
[3-[[Z-[(phenylamino) carbonyl] hydrazino] methyl]-
7-oxabicyclo [2.2.1] hept-2-yl]-,[1S-[1K,2K(Z),3K,4K]]
(SQ29,548) [1-[2-(5-carboxyoxazol-2-yl)-6-aminoben-
zofuran-2-oxy]-2-(2P-amino-5P-methylphenoxy)-eth-
ane-N,N,NPNP-tetraacetic acid, pentaacetoxymethyl
ester] (FURA2/AM), verapamil, nifedipine, TMB-8
and D-myo-inositol 1,4,5-triphosphate, 3-deoxy-hexa
sodium salt (stable analogue of IP3) were purchased
from Calbiochem. [3H]SQ29,548 (50.4 Ci/mmol) was
obtained from DuPont NEN. [3H]cAMP (15^30 Ci/
mmol) and [3H]IP3 (20^40 Ci/mmol) were obtained
from American Radiolabeled Chemicals. Antibodies
directed against the K subunits of: GK12 (AS 233)
were kindly donated by Dr Karstan Spicher, Freie
Universita«t Berlin, Germany; to GKs (SC-823), GK16
(SC-7416) and GKq/K11 (C19) antibodies, in addition
to horseradish peroxidase (HRP)-conjugated anti-
mouse, anti-rabbit or anti-goat secondary antibodies
were obtained from Santa Cruz. Chemiluminescence
Western blotting kit, polyvinylidene di£uoride
(PVDF) membrane was obtained from Roche.
2.2. Methods
2.2.1. Plasmid construction
The plasmids pCMV5 and pCMV:GK11, contain-
ing the full length coding sequence for GK11, have
previously been described [26]. The plasmids
pMOB:GK12 and pBluescript(KS) :GK16, encoding
the K subunits of the mouse G12 [36] and human
G16 heterotrimeric G protein K subunits, were kindly
donated by Dr G. Schultz, Institut fu«r Pharmakolo-
gie, Freie Universita«t Berlin, Germany, and Dr M.
Simon, California Institute of Technology, Pasadena,
CA, USA. The plasmids pCMV:GK12 and
pCMV:GK16 were constructed by subcloning the
full length coding sequence for GK12 and GK16
from pMOB:GK12 and pBluescript(KS) :GK16, re-
spectively, into the KpnI^BamHI sites of pCMV5
[37]. The plasmid pDp3:GKs encoding human GKs
was kindly donated by Dr David Manning, Univer-
sity of Pennsylvania, PA, USA. The plasmid
pCMV:GKs was constructed by subcloning the full
length coding sequence for GKs into the XbaI^Hin-
dIII sites of pCMV5 [37].
2.2.2. Cell culture and transfections
HEK 293 cells were obtained from the American
Type Culture Collection. The following HEK.K10
and HEK.L3 cell lines, stably over-expressing TPK
and TPL, respectively, have previously been de-
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scribed [27]. Construction of HEK.TPv328 cells which
over-express TPv328, a truncated variant of TP de-
void of amino acids carboxyl to Arg328 at the point
of divergence of TPK and TPL, was carried out es-
sentially as previously described [27]. Independent
isolates were characterised by saturation radioligand
binding and those isolates exhibiting [3H]SQ29,548
binding were expanded. For transient transfection
studies, HEK 293 cell lines, cultured in MEM, 10%
fetal bovine serum were plated in 100 mm culture
dishes at a density of 1.8^2U106 cells/dish approxi-
mately 48 h prior to transfection. Cells were trans-
fected with 10 Wg of pADVA [38] and 25 Wg
pCMV:GK11, pCMV:GK12, pCMV:GK16, pCMV:
GKs or pCMV5 using the calcium phosphate/DNA
co-precipitation procedure essentially as previously
described [26] and were harvested 48 h after trans-
fection.
2.2.3. Calcium measurements
Measurements of intracellular calcium ([Ca2]i) in
HEK 293 cells were made by monitoring the inten-
sity of FURA2 £uorescence essentially as previously
described [26]. Brie£y, cells were harvested by scrap-
ing, washed twice in phosphate-bu¡ered saline (PBS),
resuspended in modi¢ed Ca2/Mg2-free Hank’s
bu¡ered salt solution, containing 10 mM (N-[2-hy-
droxyethyl]piperazine-NP-(2-ethanesulfonic acid)
(HEPES), pH 7.67, 0.1% bovine serum albumin
(BSA) (HBSSHB bu¡er) at 107 cells/ml and incu-
bated in the dark with 5 WM FURA2/AM for
45 min at 37‡C. Cells were subsequently collected
by centrifugation (900Ug, 5 min), washed once in
an equal volume of HBSSHB and ¢nally resus-
pended in HBSSHB bu¡er at 107 cells/ml and kept
at room temperature in the dark until use. For each
measurement of [Ca2]i, aliquots of HEK 293 cells
were diluted to 0.825U106 cells/ml in HBSSHB bu¡-
er containing 1 mM CaCl2. FURA2 £uorescence was
recorded in gently stirred HEK 293 cells (2 ml ali-
quots) at 37‡C using a Perkin-Elmer-Cetus LS50-B
spectro£uorimeter at excitation wavelengths of
340 nm and 380 nm and emission wavelengths of
510 nm [26,39]. Cells were stimulated with 1 WM
U46619, unless otherwise speci¢ed. To examine the
e¡ect of Ca2 channel blockers, cells were pre-incu-
bated in the presence of verapamil (10 WM), nifedi-
pine (1 WM) or in the presence of TMB-8 (50 WM) for
15 min at 37‡C prior to stimulation with U46619
(1 WM). The calibration of the signal was performed
in each sample by adding 0.2% Triton X-100 to ob-
tain the maximal £uorescence (Fmax) and then adding
1 mM EGTA to obtain the minimal £uorescence
(Fmin). A rapid, transient rise and fall in [Ca2]i levels
in response to ligand stimulation was interpreted as
receptor-mediated [Ca2]i mobilisation. The ratio of
the £uorescence at 340 nm to that at 380 nm is a
measure of [Ca2]i [39], assuming a Kd of 225 nM
Ca2 for FURA2/AM. The results presented in the
¢gures are representative data from at least four in-
dependent experiments and are plotted as changes in
intracellular Ca2 mobilised (v[Ca2]i (nM)) as a
function of time (s) upon ligand stimulation.
2.2.4. Radioligand binding and Western blot analysis
HEK 293 cells were harvested by centrifugation at
500Ug at 4‡C for 5 min, were washed three times in
Dulbecco’s PBS and were resuspended in modi¢ed
Ca2/Mg2-free Hank’s-bu¡ered salt solution, con-
taining 10 mM HEPES, pH 7.67, 0.1% BSA
(HBSSHB bu¡er). Protein determinations were car-
ried out using the Bradford assay [40]. For ligand
binding studies, cells were diluted to 1 mg/ml in
HBSSHB bu¡er. Radioligand binding assays were
carried out on whole cell fractions (100 Wg) at 30‡C
for 30 min in 100 Wl reactions in the presence of 0^40
nM [3H]SQ29,548 for Scatchard analyses, for calcu-
lation of Kd and Bmax values, or in the presence of
20 nM [3H]SQ29,548, for routine radioligand binding
assays, as previously described [26,27]. Non-speci¢c
binding was determined in the presence of excess
non-labelled SQ29,548 (10 WM). Reactions were ter-
minated by the addition of 4 ml of ice-cold 10 mM
Tris^HCl, pH 7.4, followed by ¢ltration through
Whatman GF/C glass ¢lters, and subsequent wash-
ing of the ¢lters three times with 10 mM Tris^HCl,
pH 7.4, followed by liquid scintillation counting of
the ¢lters in 5 ml of scintillation £uid. Radioligand
binding data were analysed using GraphPad Prism
V2.0 (GraphPad Software) to determine the Kd and
Bmax values.
For Western blot analysis, equivalent aliquots of
whole non-fractionated cells, transiently co-trans-
fected with pCMV5 or pCMV:GK11, pCMV:GK12,
pCMV:GK16 or pCMV:GKs were solubilised by boil-
ing at 100‡C for 5 min in solubilisation bu¡er (10%
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L-mercaptoethanol, 2% sodium dodecyl sulfate
(SDS), 30% glycerol, 0.025% bromophenol blue,
50 mM Tris^HCl, pH 6.8) and were resolved on a
10% SDS^polyacrylamide gel (SDS^PAGE) followed
by Western blot transfer onto PVDF membranes es-
sentially as previously described [26]. Thereafter,
Western blots were screened with the speci¢c anti-
GK antibodies followed by chemiluminescence detec-
tion, using the relevant HRP-conjugated secondary
antibodies, according to the suppliers’ instructions.
2.2.5. Measurement of IP3 levels
Measurement of IP3 levels in HEK 293 cells was
made on the basis of competition between unlabelled
IP3 and a ¢xed concentration of [3H]IP3 for binding
to an IP3 binding protein derived from bovine adre-
nal glands, essentially as described by Godfrey [41].
Brie£y, cells were harvested by scraping, washed
twice in ice-cold PBS and 2U106 cells were resus-
pended in 200 Wl HEPES-bu¡ered saline (HBS;
140 mM NaCl, 4.7 mM KCl, 2.2 mM CaCl2,
1.2 mM KH2PO4, 11 mM glucose, 15 mM
HEPES^NaOH, pH 7.4) supplemented with 10 mM
LiCl. Cells were pre-equilibrated in this bu¡er at
37‡C for 10 min and stimulated at 37‡C for 1 min
or 5 min in the presence of U46619 (1 WM) or, to
determine basal IP3 levels in cells, in the presence of
an equivalent volume (50 Wl) of HBS vehicle. IP3 was
extracted by the addition of 50 Wl ice-cold 30% tri-
chloroacetic acid (TCA). After vortexing and centri-
fugation (3500 rpm, 5 min), 250 Wl of each super-
natant was removed to glass tubes, 1.0 ml H2O-
saturated diethyl ether was added for extraction of
TCA and the samples were placed in a methanol-dry
ice bath until the aqueous layers froze and the ether
layers could be poured o¡. Ether extraction was re-
peated three times and the samples were checked for
complete extraction of TCA (pH of sample s 5.0).
Nitrogen was bubbled through the sample to remove
diethyl ether and the pH raised to 7.0 by addition of
NaHCO3 (approximately 20 mM ¢nal concentra-
tion).
Levels of IP3 were determined by binding assays
carried out using [3H]-D-myo-IP3. Analytical samples
(100 Wl) were added to 100 Wl assay bu¡er (0.1 M
Tris^Cl, 4 mM EDTA, pH 9.0 containing 4 mg/ml
BSA). [3H]IP3 (100 Wl, 20^40 Ci/mmol, 10 mCi/ml
diluted 1:147 in H2O) was added and the tubes
were vortexed before addition of 100 Wl binding pro-
tein from bovine adrenal medulla and further vortex-
ing. The level of IP3 produced was quanti¢ed by
radioimmunoassay essentially as described by God-
frey [41]. Levels of IP3 produced by ligand stimulated
cells over basal stimulation, in the presence of HBS,
were expressed in pmol IP3/106 cells þ S.E.M. and as
fold stimulation over basal (fold increase þ S.E.M.).
The data presented are representative of four inde-
pendent experiments.
2.2.6. Measurement of cAMP
HEK 293 cell lines were washed three times in ice-
cold PBS and approximately 1^2U106 cells were re-
suspended in 200 Wl HBS (140 mM NaCl, 4.7 mM
KCl, 2.2 mM CaCl2, 1.2 mM KH2PO4, 11 mM glu-
cose, 15 mM HEPES^NaOH, pH 7.4) containing
1 mM 3-isobutyl-1-methylxanthine and pre-incu-
bated at 37‡C for 10 min. Thereafter, cells were
stimulated in the presence of 1 WM U46619 or in
the presence of HBS (50 Wl) at 37‡C for 10 min.
Alternatively, to assess TP coupling to inhibition of
adenylyl cyclase, cells were stimulated in the presence
of U46619 (10310^1035 M) plus 10 WM forskolin or,
as a control, in the presence of 10 WM forskolin
alone at 37‡C for 10 min. In all cases, ligands were
diluted in HBS and were added in a ¢nal volume of
50 Wl. Reactions were terminated by heat inactivation
(100‡C, 5 min) and the level of cAMP produced was
quanti¢ed by radioimmunoassay using the cAMP
binding protein from bovine adrenal medulla essen-
tially as described by Farndale et al. [42]. Protein
determinations were carried out using the Bradford
assay [40]. Levels of cAMP produced by U46619
stimulated cells over basal stimulation, in the pres-
ence of HBS or in the presence of 10 WM forskolin,
were expressed in pmol cAMP/mg cell protein þ
S.E.M. and as fold stimulation over basal (fold in-
crease þ S.E.M.) or as percentage cAMP produced in
U46619-stimulated cells relative to cAMP levels pro-
duced in control forskolin-treated cells (cAMP con-
tent; % of control þ S.E.M.). The data presented are
representative of three independent experiments,
each carried out in duplicate.
2.2.7. Data analyses
Radioligand binding data were analysed using
GraphPad Prism V2.0 (GraphPad Software) to de-
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termine the Kd and Bmax values. Statistical analyses
were carried out using the unpaired Student’s t test
using the Statworks Analysis Package. P values of
less than or equal to 0.05 were considered to indicate
a statistically signi¢cant di¡erence.
3. Results
3.1. TP signaling via GK16
We have previously established that the control,
non-transfected HEK 293 cells lack su⁄cient levels
of TP to support measurable intracellular signaling
in response to stimulation with the TXA2 mimetic
U46619 [26]. Moreover, in studies involving GK11
and GKq, e⁄cient U46619-mediated intracellular sig-
naling in HEK 293 cells either transiently or stably
transfected with TPK or TPL was dependent on co-
expression of the K subunit of the coupling G protein
[26,27]. Thus, in this study, in order to assess
whether the TP isoforms couple to GK16 to mediate
activation of PLCL, HEK 293 cell lines stably over-
expressing TPK (HEK.K10 cells) or TPL (HEK.L3
cells) were transiently co-transfected with GK16. TP
expression was monitored by Scatchard analyses us-
ing the selective radioligand [3H]SQ29,548 and PLCL
activation was monitored by measurement of IP3
generation and mobilisation of [Ca2]i in response
to U46619. TPK and TPL signaling in the presence
of GK16 was compared to that observed in the pres-
ence of GK11 or, as a control, in the presence of the
vector pCMV5. Co-expression of HEK.K10 cells (Kd
5.56 þ 0.98 nM, Bmax 3.38 þ 0.08 pmol/mg cell pro-
tein) or HEK.L3 cells (Kd 8.44 þ 1.44 nM, Bmax
3.24 þ 0.33 pmol/mg cell protein) with GK16 or
GK11 or pCMV5 produced no signi¢cant change in
the a⁄nities of either TPK or TPL for SQ29,548
(data not shown). Con¢rmation of G protein over-
expression in the various HEK 293 cell lines was
routinely performed by Western blot analysis using
antibodies speci¢c to GK11 and GK16 (Fig. 1B,D).
To assess whether TPK or TPL couple to GK16 to
Fig. 1. Western blot analysis. HEK 293 cells were transiently
co-transfected with the cDNA encoding GKs (A, +), GK11 (B,
+), GK12 (C, +), GK16 (D, +) or as a control, with the vector
pCMV5 (A^D, 3). Forty-eight hours post-transfection, cells
were harvested and aliquots (100 Wg) of whole cell protein were
subjected to SDS^PAGE followed by Western blot analysis.
The blots presented are representative of at least four independ-
ent experiments. The relative position of the 46 kDa molecular
weight marker is indicated by an arrow at the left of each pan-
el. Similar levels of G protein expression were observed in
HEK.K10, HEK.L3 and HEK.TPv328 cell lines transiently co-
transfected with the various G protein K subunits.
Fig. 2. U46619-mediated IP3 production in HEK.K10 and
HEK.L3 cells co-transfected with GK11 or GK16. HEK.K10 cells
(A) or HEK.L3 cells (B), transiently co-transfected with the
cDNA encoding GK11 or GK16 or as a control, with the vector
pCMV5, were stimulated with 1 WM U46619 at 37‡C for 1 min
or 5 min. In each case, basal IP3 levels were determined by ex-
posing the cells to the vehicle HBS under identical conditions.
Levels of IP3 produced in ligand-stimulated cells relative to ve-
hicle-treated cells (basal IP3) were expressed as fold stimulation
of basal (fold increase in IP3 þ S.E.M.). The data presented are
the mean values of four independent experiments, each carried
out in duplicate. **(P6 0.02) or ***(P6 0.005) indicate that
U46619-induced IP3 levels were signi¢cantly higher in cells co-
transfected with GK11 or GK16 than in cells co-transfected with
pCMV5.
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mediate changes in intracellular signaling, cells were
stimulated with either U46619 (1 WM) or vehicle
(HBS) for 1 min or 5 min; levels of IP3 generation
were measured and expressed as fold increase over of
basal IP3 levels in HBS-treated cells (Fig. 2A,B).
Consistent with previous data [26,43], dose^response
studies established that 1 WM U46619 elicited max-
imal IP3 generation and [Ca2]i mobilisation by both
TPK and TPL. For both HEK.K10 and HEK.L3
cells, co-transfection of pCMV5 did not support sig-
ni¢cant increases in IP3 generation in response to
U46619 over basal levels, whereas co-transfection
of cells with either GK11 or GK16 generated signi¢-
cant increases in IP3 levels (Fig. 2A,B). In general,
elevation of IP3 levels was transient, with maximal
levels observed following 1 min stimulation with
U46619 (Fig. 2A,B). The level of IP3 generation
compared well to previously published IP3 data fol-
lowing stimulation of the mouse TP with 1 WM
U46619 [44]. In the case of HEK.K10 cells, both
GK11 and GK16 co-transfection facilitated stimulation
of IP3 levels in response to U46619 to similar extents
(Fig. 2A). In the case of HEK.L3 cells, levels of
U46619-mediated IP3 generation in cells co-trans-
fected with GK16 were not signi¢cantly di¡erent
than those observed in cells co-transfected with
GK11 (Fig. 2B; P = 0.125 for 1 min of treatment).
Moreover, comparing HEK.K10 to HEK.L3 cells,
the IP3 levels generated with either GK11 or GK16
were not signi¢cantly di¡erent between the two cell
types (P = 0.329 for TPK versus TPL in the presence
of GK11, P = 0.093 for TPK versus TPL in the pres-
ence of GK16 for 1 min U46619 treatment), indicat-
ing that TPK and TPL couple similarly to these mem-
bers of the Gq family in this system.
Coupling of TPK and TPL to GK11 and GK16 was
also evaluated by measurement of intracellular calci-
um ([Ca2]i) mobilisation in response to stimulation
of cells with U46619. HEK.K10 or HEK.L3 cells
were transiently co-transfected with the cDNA for
the appropriate GK protein or, as a control, with
pCMV5 and cells were loaded with FURA2/AM be-
fore measurement of [Ca2]i mobilisation in response
to U46619. Dose^response studies con¢rmed that
Fig. 3. U46619-mediated [Ca2]i mobilisation in HEK.K10 and HEK.L3 cells co-transfected with GK11 or GK16. HEK.K10 cells
(A and B) or HEK.L3 cells (C and D), transiently co-transfected with the cDNA encoding GK11 or GK16 or, as a control, with the
vector pCMV5, were pre-loaded with FURA2/AM and stimulated with 1 WM U46619. A and C: The data presented are a representa-
tive pro¢le from at least four independent experiments and are plotted as changes in intracellular Ca2 mobilised (v[Ca2]i, nM) as a
function of time (s) following ligand stimulation where U46619 was added at the times indicated by the arrows. B and D: For each
experiment, the mean values for changes in U46619-mediated intracellular Ca2 mobilised from at least four independent experiments
were calculated; mean data are plotted as changes in intracellular Ca2 mobilised (v[Ca2]i þ S.E.M., nM; n = 4) versus G protein.
***(P6 0.005) indicates that U46619-induced v[Ca2]i was signi¢cantly higher in cells co-transfected with GK11 or GK16 than in cells
co-transfected with pCMV5.
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1 WM U46619 was necessary to elicit maximal Ca2
mobilisation, consistent with previously published
data [26]. Co-transfection of cells with GK11 and
GK16 signi¢cantly increased U46619 (1 WM)-medi-
ated [Ca2]i mobilisation by both HEK.K10 (Fig.
3A,B) and HEK.L3 (Fig. 3C,D) cells over levels ob-
tained with pCMV5-transfected cells (Fig. 3) or non-
transfected cells (data not shown). However, for ex-
ample, in the case of HEK.K10 cells co-transfected
with GK11, raising the agonist concentration to
10 WM U46619 did not signi¢cantly increase [Ca2]i
mobilisation (P = 0.712) whilst lowering the concen-
tration to 0.1 WM signi¢cantly (P6 0.05) reduced
[Ca2]i mobilisation. Similar results were observed
for GK16 and in HEK.L3 cells. However, there was
no signi¢cant di¡erence in signaling between
HEK.K10 and HEK.L3 cells in the presence of either
G protein, indicating that TPK or TPL do not di¡er-
entially couple to GK11 or GK16.
3.2. Signaling via GK12
A number of independent studies have indicated
that the TP(s) may couple to members of the G12
family [21^24] although the intracellular e¡ectors in-
£uenced by these G proteins are unclear. To assess
whether TPK or TPL couple to GK12, HEK.K10 and
HEK.L3 cells were transiently co-transfected with the
cDNA for GK12 and U46619-mediated intracellular
signaling was monitored. Co-expression of GK12 did
not signi¢cantly a¡ect the Kd or Bmax of HEK.K10 or
HEK.L3 cells for SQ29,548. Con¢rmation of G pro-
tein over-expression in the various HEK 293 cell
lines was routinely performed by Western blot anal-
ysis using antibodies speci¢c to GK12 (Fig. 1C). For
either cell type co-transfected with GK12, stimulation
of cells with 1 WM U46619 (Fig. 4A,B) or 10 WM
U46619 (data not shown) failed to generate signi¢-
cant elevations of IP3 levels, despite the fact that
1 WM U46619 has been established to elicit maximal
TP responses [42,26]. In fact, U46619-mediated IP3
levels in HEK.K10 or HEK.L3 cells in the presence of
GK12 were not signi¢cantly greater than those gener-
ated by cells co-transfected with pCMV5 control
(Fig. 4A,B), con¢rming that neither TPK nor TPL
couple via GK12 to activate PLCL isoforms and in-
crease IP3 levels. However, HEK.K10 and HEK.L3
cells co-transfected with GK12 each exhibited signi¢-
cantly greater mobilisation of Ca2 compared to
those cells co-transfected with pCMV5 (Fig. 5).
Dose^responses con¢rmed that maximal [Ca2]i mo-
bilisation was stimulated by 1 WM U46619; for ex-
ample, in HEK.K10 cells co-transfected with GK12,
raising the concentration of U46619 to 10 WM did
not signi¢cantly (P = 0.67) increase [Ca2]i mobilisa-
tion whereas lowering the concentration to 0.1 WM
U46619 signi¢cantly reduced Ca2 mobilisation
(P6 0.05). Similar results were obtained in HEK.L3
cells. These results implied that the maximal Ca2
mobilisation observed in HEK.K10 and HEK.L3 cells
co-transfected with GK12 was the result of a separate
mechanism to that of GK11 or GK16 and did not
Fig. 4. U46619-mediated IP3 production in HEK.K10 and
HEK.L3 cells co-transfected with GK12. HEK.K10 cells (A) or
HEK.L3 cells (B), transiently co-transfected with the cDNA en-
coding GK12 or as a control, with the vector pCMV5, were
stimulated with 1 WM U46619 at 37‡C for 1 min or 5 min. In
each case, basal IP3 levels were determined by exposing the
cells to the vehicle HBS under identical conditions. Levels of
IP3 produced in ligand-stimulated cells relative to vehicle-
treated cells (basal IP3) were expressed as fold stimulation of
basal (fold increase in IP3 þ S.E.M.). The data presented are the
mean values of four independent experiments, each carried out
in duplicate.
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involve PLCL activation and phosphoinositide turn-
over.
3.3. In£ux of calcium via verapamil-sensitive Ca2+
channels is a major element in GK12 coupling in
HEK 293 cells
To further investigate the mechanism of U46619-
mediated increases in [Ca2]i in HEK.K10 and
HEK.L3 cells co-transfected with GK12, we examined
the e¡ect of verapamil, an inhibitor of voltage de-
pendent Ca2 channels, principally the L-type chan-
nels [34], on [Ca2]i mobilisation in cells co-trans-
fected with GK12 and compared it to its e¡ect on
those cells co-transfected with GK11. U46619-medi-
ated Ca2 mobilisation was assessed in FURA2/
Fig. 5. U46619-mediated [Ca2]i mobilisation in HEK.K10 and HEK.L3 cells co-transfected with GK12. HEK.K10 cells (A and B) or
HEK.L3 cells (C and D), transiently co-transfected with the cDNA encoding GK12 or as a control, with the vector pCMV5, were pre-
loaded with FURA2/AM and stimulated with 1 WM U46619. A and C: The data presented are a representative pro¢le from at least
four independent experiments and are plotted as changes in intracellular Ca2 mobilised (v[Ca2]i, nM) as a function of time (s) fol-
lowing ligand stimulation where U46619 was added at the times indicated by the arrows. B and D: For each experiment, the mean
values for changes in U46619-mediated intracellular Ca2 mobilised from at least four independent experiments were calculated; mean
data are plotted as changes in intracellular Ca2 mobilised (v[Ca2]i þ S.E.M., nM; n = 4) versus G protein. ***(P6 0.005) indicates
that U46619-induced v[Ca2]i was signi¢cantly higher in cells co-transfected with GK12 than in cells co-transfected with pCMV5.
C
Fig. 6. E¡ect of verapamil on U46619-mediated [Ca2]i mobilisation by TPK and TPL. HEK.K10 cells (A, B and E) and HEK.L3 cells
(C, D and F) transiently co-transfected with the cDNA encoding GK11 (A, C, E, F) or GK12 (B, D, E, F) were pre-loaded with
FURA2/AM and stimulated with either 1 WM U46619 or were pre-incubated in the presence of verapamil (10 WM) at 37‡C for 15 min
prior to stimulation with 1 WM U46619. A^D: The data presented are a representative pro¢le from at least four independent experi-
ments and are plotted as changes in intracellular Ca2 mobilised (v[Ca2]i, nM) as a function of time (s) following ligand stimulation
where U46619 was added at the times indicated by the arrows. E and F: Changes in U46619-mediated intracellular Ca2 mobilised
(v[Ca2]i þ S.E.M., nM; n = 4) were calculated; those levels of [Ca2]i mobilised following stimulation with U46619 only (3verapamil)
were set to represent 100% and thereafter, the levels of U46619-mediated [Ca2]i mobilised subsequent to prior stimulation with vera-
pamil (+verapamil) were calculated as a percentage of that value. Data are plotted as U46619-mediated Ca2i mobilisation, percentage
(U46619 Ca2i mobilisation (%)) versus G protein. *(P6 0.05) indicates that U46619-induced v[Ca
2]i was signi¢cantly lower in cells
co-transfected with GK12 treated with verapamil than in untreated cells. G: HEK.K10 cells and HEK.L3 cells transiently co-transfected
with the cDNA encoding GK12 or with pCMV5 were pre-loaded with FURA2/AM. Cells co-transfected with GK12 were pre-incubated
in the presence of verapamil (10 WM) at 37‡C for 15 min prior to stimulation with 1 WM U46619. Cells co-transfected with pCMV5
were stimulated with 1 WM U46619. Data are plotted as U46619-mediated Ca2i mobilisation (nM) (v[Ca
2]i þ S.E.M., nM; n = 3) ver-
sus cell type.
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AM-loaded HEK.K10 and HEK.L3 cells in the pres-
ence or absence of pre-treatment with verapamil
(10 WM, 15 min pre-treatment). Initially, it was es-
tablished that this treatment did not signi¢cantly
(P = 0.269) a¡ect basal Ca2 levels. Pre-treatment
of HEK.K10 cells co-transfected with GK11 with ve-
rapamil did not signi¢cantly reduce U46619-medi-
ated [Ca2]i mobilisation (P = 0.254; Fig. 6A,E).
However, verapamil pre-treatment of HEK.K10 cells
co-transfected with GK12 reduced Ca2 mobilisation
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(Fig. 6B,E) to 43.3 þ 3.26% of untreated levels, a sig-
ni¢cantly (P6 0.05) greater reduction than in those
cells transfected with GK11. The extent of U46619-
mediated [Ca2]i mobilisation remaining in the pres-
ence of verapamil was not signi¢cantly (P = 0.31) dif-
ferent from the small basal level observed in
HEK.K10 cells in the absence of co-transfected G
protein (Figs. 3, 5 and 6G). This implies that
[Ca2]i mobilisation mediated due to TP coupling
to GK12 triggers in£ux of Ca2 due to verapamil-
sensitive channel opening. In HEK.L3 cells co-trans-
fected with GK11, verapamil did not a¡ect U46619-
mediated [Ca2]i mobilisation (Fig. 6C,F). However,
verapamil reduced Ca2 mobilisation in HEK.L3
cells co-transfected with GK12 to 37.8 þ 12.9% of
that mobilised in its absence (Fig. 6D,F). Similar to
HEK.K10 cells, the extent of U46619-mediated
[Ca2]i mobilisation remaining in the presence of ve-
rapamil was not signi¢cantly (P = 0.877) di¡erent
from that in HEK.L3 cells in the absence of co-trans-
fected G protein (Figs. 3, 5 and 6G). These results
imply that the Ca2 mobilisation observed in both
HEK.K10 or HEK.L3 cells co-transfected with GK12
was largely due to in£ux of Ca2 via opening of
verapamil-sensitive membrane Ca2 channels.
To further investigate the mechanism of U46619-
mediated increases in [Ca2]i in HEK.K10 and
HEK.L3 cells co-transfected with GK12, we also ex-
amined the e¡ect of TMB-8, which selectively blocks
the release of Ca2 from intracellular stores [35] on
[Ca2]i mobilisation in cells co-transfected with
GK12, and compared it to its e¡ect on those cells
co-transfected with GK11. HEK.K10 or HEK.L3
cells, transiently co-transfected with either GK11 or
GK12, were loaded with FURA2/AM prior to treat-
ment with TMB-8 (50 WM) for 15 min. At the con-
centrations used, TMB-8 partially reduced the mobi-
lisation of [Ca2]i in both HEK.K10 (Fig. 7A,E) and
HEK.L3 (Fig. 7C,F) cells co-transfected with GK11
to 59.1 þ 12.2% and 76.7 þ 11.1%, respectively. How-
ever, TMB-8 did not reduce [Ca2]i mobilisation in
either cell type co-transfected with GK12 (Fig. 7B,D^
F). The e¡ects of TMB-8 on GK11, but not on GK12,
-coupled signaling further con¢rm that TPK- and
TPL-mediated [Ca2]i mobilisation via GK11 is de-
pendent on sources of intracellular Ca2 but that
neither TP isoform mobilises Ca2 from intracellular
sources upon coupling to GK12.
3.4. The carboxyl-terminal C-tail of TPs contains
determinants of G protein coupling e⁄ciency
TPK and TPL di¡er exclusively in their C-tail re-
gions and previous studies have indicated that the TP
isoforms may di¡erentially couple to GKs, GKi and
Gh [28,33]. Thus, to assess whether a C-tail per se is
important in mediating TP coupling to the Gq or G12
family of heterotrimeric G proteins, we investigated
U46619-mediated intracellular signaling and G pro-
tein coupling by HEK.TPv328 cells which over-ex-
press a truncated variant of TP (TPv328) lacking the
C-tail sequences distal to amino acid 328 at the point
of divergence of TPK and TPL. TPv328 exhibited
identical [3H]SQ29,548 radioligand binding charac-
teristics (Kd 6.96 þ 0.88 nM; Bmax 1.54 þ 0.28 pmol/
mg cell protein) to those of the wild type TPK and
TPL receptors. Thereafter, the e¡ect of U46619-
mediated [Ca2]i mobilisation by TPv328 was com-
pared to that of the wild type TPK and TPL recep-
tors in the presence or absence of co-transfection of
GK11, GK12 or GK16. Non-transfected HEK.TPv328
cells (data not shown) or cells co-transfected with
the vector pCMV5 exhibited a signi¢cantly greater
change in [Ca2]i mobilisation in response to
U46619 than did HEK.K10 (P6 0.02) or HEK.L3
(P6 0.02) cells transfected with pCMV5 (Fig. 8A).
However, unlike that observed for HEK.K10 or
HEK.L3 cells, co-transfection of HEK.TPv328 cells
with either GK11, GK12 or GK16 did not signi¢cantly
enhance the levels of [Ca2]i mobilisation in either
case (Fig. 8B^E). To con¢rm these data, we investi-
gated the e¡ect of co-expressing GK subunits on
U46619-mediated [Ca2]i in a second, independent
isolate (isolate B) of HEK.TPv328 cells which over-
expresses higher levels of TPv328 (Bmax = 2.33 þ 0.096
pmol/mg cell protein, n = 4) than the previously de-
scribed HEK.TPv328 cells (isolate A). Consistent with
previous data, whereas HEK.TPv328 isolate B exhib-
ited slightly higher U46619-mediated signaling than
the original isolate A in both non-transfected cells or
in cells co-transfected with pCMV5, co-expression of
either GK11, GK12 or GK16 did not signi¢cantly aug-
ment [Ca2]i mobilisation by that cell line (Fig. 9).
Taken together, these results imply that although the
C-tail of TP does not appear to dictate speci¢city of
G protein coupling to the Gq or G12 members exam-
ined, the presence of a C-tail may be important for
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controlled and e⁄cient G protein coupling and that
it may actually confer negative regulatory e¡ects on
receptor:G protein interaction.
To extend these studies, as TPK and TPL di¡er
exclusively in their C-tail sequences and they oppo-
sitely regulate adenylyl cyclase, we also investigated
TPv328 signaling to the e¡ector adenylyl cyclase. For
these studies, HEK 293 cells were transiently trans-
fected with TPK, TPL or TPv328. Whereas stimula-
tion of cells expressing TPK with U46619 (1 WM) led
to an approximately 1.5-fold increase in cAMP, stim-
ulation of cells expressing TPv328 led to a signi¢-
cantly (P = 0.002) higher generation of cAMP (Fig.
10A). On the other hand, stimulation of cells express-
Fig. 7. E¡ect of TMB-8 on U46619-mediated [Ca2]i mobilisation by TPK and TPL. HEK.K10 cells (A, B and E) and HEK.L3 cells
(C, D and F) transiently co-transfected with the cDNA encoding GK11 (A, C, E, F) or GK12 (B, D, E, F) were pre-loaded with
FURA2/AM and stimulated with either 1 WM U46619 or were pre-incubated in the presence of TMB-8 (50 WM) at 37‡C for 15 min
prior to stimulation with 1 WM U46619. A^D: The data presented are a representative pro¢le from at least four independent experi-
ments and are plotted as changes in intracellular Ca2 mobilised (v[Ca2]i, nM) as a function of time (s) following ligand stimulation
where U46619 was added at the times indicated by the arrows. E and F: Changes in U46619-mediated intracellular Ca2 mobilised
(v[Ca2]i þ S.E.M., nM; n = 4) were calculated; those levels of [Ca2]i mobilised following stimulation with U46619 only (3TMB-8)
were set to represent 100% and thereafter, the levels of U46619-mediated [Ca2]i mobilised subsequent to prior stimulation with
TMB-8 (+TMB-8) were calculated as a percentage of that value. Data are plotted as U46619-mediated Ca2i mobilisation, percentage
(U46619 Ca2i mobilisation (%)) versus G protein. *(P6 0.05) or **(P6 0.02) indicate that U46619-induced v[Ca
2]i was signi¢cantly
lower in cells co-transfected with GK11 treated with TMB-8 than in untreated cells.
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ing TPL failed to generate an increase in cAMP but
did reduce forskolin-mediated cAMP generation,
consistent with its coupling to GKi in these cells
(Fig. 10B). Neither TPK nor TPv328 showed coupling
to GKi whereas TPL showed signi¢cant coupling to
GKi (P6 0.05, 1 WM U46619; Fig. 10B). Whilst co-
transfection of GKs with TPK facilitated a signi¢cant
(P6 0.02) augmentation in U46619 (1 WM) -medi-
ated cAMP generation, it did not lead to a signi¢cant
(P = 0.58) augmentation in cAMP by TPv328. Con¢r-
mation of G protein over-expression in the various
HEK 293 cell lines was routinely performed by West-
Fig. 8. U46619-mediated [Ca2]i mobilisation in HEK.TPv328 cells co-transfected with GK11, GK12 or GK16. HEK.TPv328, HEK.K10 or
HEK.L3 cells, transiently co-transfected with pCMV5 (A), or HEK.TPv328, transiently co-transfected with the cDNA encoding GK11
or GK16 (B and C) or GK12 (D and E) or as controls, with the vector pCMV5 (A^E), were pre-loaded with FURA2/AM and stimu-
lated with 1 WM U46619. B and D: The data presented are a representative pro¢le from at least four independent experiments and
are plotted as changes in intracellular Ca2 mobilised (v[Ca2]i þ S.E.M., nM) as a function of time (s) following ligand stimulation
where U46619 was added at the times indicated by the arrows. A, C and E: For each experiment, the mean values for changes in
U46619-mediated intracellular Ca2 mobilised from at least four independent experiments were calculated; mean data are plotted as
changes in intracellular Ca2 mobilised (v[Ca2]i þ S.E.M., nM; n = 4) versus G protein. **(P6 0.02) indicates that U46619-induced
v[Ca2]i was signi¢cantly higher in HEK.TPv328 cells co-transfected with pCMV5 than in HEK.K10 or HEK.L3 cells co-transfected
with pCMV5.
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ern blot analysis using antibodies speci¢c to GKs
(Fig. 1A). Thus, similar to the TPK, but not the
TPL isoform, TPv328 exhibited U46619-mediated ac-
tivation of adenylyl cyclase, with concomitant in-
creases in cAMP generation. However, TPv328 exhib-
ited signi¢cantly higher cAMP generation than TPK
in the absence of exogenous G protein, yet displayed
an impaired ability to couple to co-transfected GKs.
4. Discussion
In this study, we have investigated the functional
coupling of the K and L isoforms of the human TP to
GK16, GK12 and GKs in HEK 293 cells over-express-
ing the individual TP isoforms in order to determine
whether divergence in the C-tail sequences between
the receptor isoforms in£uences G protein coupling
speci¢city. HEK 293 cells lack su⁄cient endogenous
levels of TP expression to permit measurement of
intracellular signaling, despite the presence of
mRNAs encoding both TP isoforms (Miggin and
Kinsella, unpublished data). Furthermore, HEK
293 cells either transiently or stably transfected
with TP did not exhibit signi¢cant agonist-mediated
[Ca2]i mobilisation unless they were co-transfected
with GKq or GK11 [26,27], similar to the K2-adreno-
receptor stimulation of PLCL activity in HEK 293
cells which is completely dependent on the co-expres-
sion of GKq [45].
Our results demonstrated that TPK and TPL each
exhibited similar U46619-mediated coupling to GK11
and GK16 to a¡ect increases in IP3 and mobilisation
of [Ca2]i. Coupling of the TP isoforms to GK16 is
Fig. 9. E¡ect of G protein K subunits on U46619-mediated [Ca2]i mobilisation in an independent isolate of HEK.TPv328 cells.
HEK.TPv328 cells (isolate B) were transiently co-transfected with pCMV5 (A), pCMV5:GK11 (B), pCMV5:GK12 (C) or pCMV5:GK16
(D). After 48 h, cells were harvested, pre-loaded with FURA2/AM and stimulated with U46619 (1 WM). The ligand was added at the
times indicated by the arrows. The results are representative of at least three independent experiments and are plotted as changes in
intracellular Ca2 mobilised (v[Ca2]i (nM)) as a function of time (s) following ligand stimulation. Levels of U46619-mediated [Ca2]i
mobilisation in HEK.TPv328 cells were not signi¢cantly di¡erent in the presence of co-transfected G proteins than in cells co-trans-
fected with the vector pCMV5.
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consistent with its expression in platelets and other
megakaryocytic cells [20,46]. In fact, it has been sug-
gested that the expression of GK16 mRNA and pro-
tein in various megakaryoblastic cell lines of increas-
ing maturation corresponds to the appearance of
TXA2-induced signaling ([Ca2]i mobilisation and
stimulation of PGI2-induced cAMP formation) in
megakaryocytic cell lineages [20].
Whereas both TPK and TPL did exhibit increases
in [Ca2]i mobilisation in cells co-transfected with
GK12, neither receptor generated IP3 increases in
the presence of GK12. Verapamil, an inhibitor of
voltage dependent Ca2 channels, principally the
L-type Ca2 channels [34], signi¢cantly reduced
[Ca2]i mobilisation by TPK and TPL in cells co-ex-
pressing GK12, but not GK11, implying that in this
system TPK and TPL couple via GK12 to activate an
endogenous, verapamil-sensitive voltage dependent
membrane calcium channel. The possible involve-
ment of L-type channels was also con¢rmed with
nifedipine, an alternative L-type Ca2 channel block-
er, which caused signi¢cant reductions in GK12-
coupled mobilisation of [Ca2]i by either TPK or
TPL in response to U46619. However, this com-
pound signi¢cantly (P6 0.005) perturbed basal
Ca2 levels, making it less suitable for studies involv-
ing FURA2-based Ca2 measurements (results not
shown). It has been reported that the endogenous
Ca2 channels in HEK 293 cells di¡er somewhat
from L-type channels in terms of kinetic properties
and pharmacological features [47]. However, they are
sensitive to the e¡ects of the L-type channel inhibitor
isradipine, a dihydropyridine and nimodipine but
somewhat insensitive to blockers of N-, P- and
Q-type channels a⁄rming the existence of L-type
Ca2 channels in HEK 293 cells [47]. Consistent
with these studies, Tosun et al. [51] reported that
TP-mediated contraction of rat aortic smooth muscle
is partially dependent on the in£ux of extracellular
Ca2 from verapamil-sensitive L-type Ca2 channels.
TMB-8, an antagonist of intracellular Ca2 mobili-
sation widely used to distinguish dependence on in-
tracellular versus extracellular Ca2 [35], reduced
[Ca2]i mobilisation by both TPK and TPL in the
presence of GK11 but not in the presence of GK12,
thereby con¢rming that GK12-mediated mobilisation
of Ca2 is not from intracellular stores. Whilst TMB-
8 has been demonstrated to have e¡ects other than
Fig. 10. TPv328 couples to activation, rather than inhibition, of
adenylyl cyclase. (A) HEK 293 cells transiently transfected with
TPK, TPL or TPv328 were co-transfected with pCMV5 (3GKs)
or with pCMV:GKs (+GKs) and were stimulated either with
1 WM U46619 or, as a control, with the vehicle HBS at 37‡C
for 10 min. Levels of cAMP produced in ligand- or vehicle-
treated cells were calculated as the mean value per mg cell pro-
tein þ S.E.M., n = 3 (pmol cAMP/mg cells þ S.E.M.) and are pre-
sented as levels of cAMP produced in U46619-stimulated cells
relative to basal cAMP levels produced by vehicle-treated cells
(fold increase in cAMP þ S.E.M.). **(P6 0.02) indicates that
U46619-induced cAMP was signi¢cantly higher in TPK cells co-
transfected with pCMV:GKs than in cells co-transfected with
pCMV5. ***(P6 0.005) indicates that U46619-induced cAMP
was signi¢cantly higher in TPv328 cells co-transfected with
pCMV5 than in cells co-transfected with pCMV5. (B) HEK 293
cells transiently transfected with TPK, TPL or TPv328 were
stimulated either with U46619 (10310^1035 M) in the presence
of 10 WM forskolin or, as a control, in the presence of 10 WM
forskolin at 37‡C for 10 min. Levels of cAMP produced in li-
gand-stimulated or control cells were calculated as the mean
value per mg cell protein þ S.E.M., n = 3 (pmol cAMP/mg
cells þ S.E.M.), and are presented as a percentage cAMP pro-
duced in U46619-stimulated cells relative to cAMP levels pro-
duced by forskolin-treated cells (cAMP content, % of control þ
S.E.M.). Only TPL showed a signi¢cant reduction in forskolin-
induced cAMP (P6 0.05, 1 WM U46619).
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antagonism of intracellular Ca2, for example in an-
tagonism of muscarinic receptor in the HT29 epithe-
lial cell line, functional antagonism of nicotinic ace-
tylcholine receptors, and inhibition of transcription
factor NF-UB activation [48^50], it seems unlikely,
particularly in the context of the verapamil studies,
that these e¡ects are relevant in the case of TP-medi-
ated signaling. A number of GPCRs have been re-
ported to stimulate Ca2 in£ux by activation of L-
type Ca2 channels including the novel TM4 splice
variant of the pituitary adenylate cyclase-activating
polypeptide receptor [52] and angiotensin 1 [53]. In
the present study, we have established that whereas
GK12 did not couple TPK or TPL to PLC activation,
that GK12 does couple each receptor to verapamil-
sensitive Ca2 channels, consistent with L-type chan-
nels.
A number of independent studies have implicated
TP coupling to members of the G12 family [21^24,54]
and the presence of both GK12 and GK13 in platelets
and other hematopoietic cells has been widely re-
ported [22,55,56]. Both GK12 and GK13 have been
shown to be activated by TP(s) in human platelets
[22]. Moreover, activation of human platelets with
the TP agonist U46619 leads to phosphorylation of
both GK12 and GK13 by a mechanism involving PKC
[56]. In general, the immediate e¡ectors coupled to
the G12 family are unknown. They have been impli-
cated in transduction of thrombin receptor activation
of AP-1-mediated gene expression [57], activation of
Jun kinase/stress-activated protein kinase and activa-
tion of di¡erent isoforms of a growth factor-respon-
sive Na/H exchanger present in most cells [58,59].
Thus, our data indicate that TPK and TPL couple
almost identically to GK11 and GK16 members of the
Gq family and to GK12, in response to the TP ago-
nist, U46619, in stably transfected HEK 293 cells. In
dose^response experiments, we found that 1 WM
U46619 was required for maximal IP3 generation
and [Ca2]i mobilisation in HEK.K10 and HEK.L3
stable cell lines transiently co-transfected with G pro-
teins (GK11, GK16 and GK12), with respective EC50
values of approximately 50 nM observed in each
case, regardless of the G protein used. This is con-
sistent with previous reports concerning GK11-medi-
ated coupling to PLC activation [27]. However, in
transfected CHO cells, they oppositely regulate ad-
enylyl cyclase [28] and have recently been shown to
couple di¡erentially to the high molecular weight G
protein Gh in COS-7 cells [33]. This implies that the
di¡erence in the C-tail may in£uence speci¢city of G
protein coupling and hence downstream signaling
events, as is the case for other GPCR isoforms which
diverge exclusively in their C-tail sequences, for ex-
ample the EP3 isoform of the PGE2 receptor [12,60]
and a wide variety of other GPCRs [61]. Thus in this
study, we also used cells which over-express TPv328, a
variant of TP lacking the C-tail sequences at the
point of divergence of TPK and TPL distal to amino
acid 328, to investigate whether the C-tail per se is
important in mediating TP coupling to GK11, GK16
or GK12. Whereas TPv328 exhibited identical ligand
binding properties to the wild type TP isoforms, sig-
naling was signi¢cantly reduced. However, non-
transfected HEK.TPv328 cells or cells co-transfected
with the vector pCMV5 exhibited a signi¢cantly
greater increase in [Ca2]i mobilisation in response
to U46619 than did HEK.K10 or HEK.L3 cells. Un-
like TPK or TPL, however, co-expression of GK11,
GK12 or GK16 did not signi¢cantly enhance recep-
tor-mediated [Ca2]i mobilisation or IP3 generation
(results not shown) by TPv328. These e¡ects were in-
dependent of the level of TP expression, as two in-
dependent isolates of HEK.TPv328 cells which ex-
press TPv328 at varying levels exhibited this e¡ect.
Thus, to extend our studies on the signaling of the
TPv328, we sought to establish whether it coupled to
GKs or GKi to mediate activation or inhibition of
adenylyl cyclase, respectively. Moreover, we sought
to investigate the e¡ect of co-expression of the cou-
pling G protein (GKs or GKi) on second messenger
generation by TP. Our ¢ndings were that, like TPK,
TPv328 mediated activation of adenylyl cyclase in re-
sponse to U46619 stimulation to bring about in-
creases in cAMP formation but unlike TPL, it failed
to couple to GKi to inhibit adenylyl cyclase. How-
ever, in the absence of co-transfection of GKs, cAMP
generation by TPv328 was signi¢cantly greater than
that of TPK. Over-expression of GKs signi¢cantly
augmented cAMP generation by TPK but had no
e¡ect on cAMP generation by TPv328 in response
to U46619.
These results indicate that whilst the C-tail per se
may not determine G protein speci¢city, it may play
a role in in£uencing Gs versus Gi coupling and it
may confer regulatory e¡ects that in£uence recep-
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tor:G protein interaction. In studies involving the
mouse TP, Spurney and Co¡man [62] previously re-
ported that the C-terminal 20 amino acids of the
single mouse TP were required for optimal intracel-
lular signaling and also played a role in mediating
homologous and, in part, heterologous desensitisa-
tion of TP. In many mammalian species, several C-
tail splice variants exist for the PGE2 receptor sub-
type 3 (EP3) [12^16]. For example, in mouse there
are four receptor subtypes with di¡erent G protein
coupling speci¢cities [13,14]. The EP3K receptor ex-
hibits some agonist independent constitutive inhibi-
tion of adenylyl cyclase whereas the EP3L receptor
does not [63]. However, a mutant receptor truncated
at the splicing site showed full constitutive activity. A
chimeric receptor composed of the N-terminal do-
main to transmembrane domain 7 of the Gi-coupled
rat EP3L receptor and the C-tail of the Gs-coupled
human EP4 receptor were used to test the e¡ect of
the C-tail on G protein coupling speci¢city and con-
stitutive activity [64]. Whilst there was no agonist
independent receptor signaling, the chimeric receptor
behaved as a Gi- rather than a Gs-coupled receptor,
indicating that the C-tail did not confer G protein
coupling speci¢city but did maintain the receptor in a
state whereby signaling arose only in response to
agonist [59]. In this study, we also demonstrate that
whilst the C-tail of the TP isoforms apparently does
not confer G protein coupling speci¢city to members
of the Gq or G12 families in HEK 293 cells, it may
play a role in determining Gs versus Gi coupling and
it may be necessary for controlled, e⁄cient G protein
coupling and intracellular signaling.
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